Andere talen Achilles Therapeutics plc

Aandelen

ACHL

US00449L1026

Beurs gesloten - Nasdaq Andere beurzen 22:30:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,7744 ^USD	-1,20%		-3,20%	-12,89%

05/04	ACHILLES THERAPEUTICS PLC : Chardan Research herhaalt koopadvies	ZM
05/04	ACHILLES THERAPEUTICS PLC : Piper Sandler verlaagt advies naar Neutraal	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

ADRs Close Lower; Moatable Inc. Declines 33.3%	04/04
Syncona notes investee Achilles's annual loss narrows	04/04
Achilles Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Business Highlights	04/04
Achilles Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2023	04/04
Achilles Therapeutics plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	04/04
Achilles Therapeutics Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning	04/04
Achilles Therapeutics plc Provides Interim Phase I/IIa Update on Clonal Neoantigen Reactive T Cells in Advanced NSCLC and Melanoma Including First Patients Dosed with Enhanced Host Conditioning	04/04
Achilles Therapeutics to Present at the 10th Annual Immuno-Oncology 360 Conference	05/02
Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction	18/12
Syncona notes investee company's quarterly loss	14/11
Achilles Therapeutics Reports Third Quarter 2023 Financial Results and Recent Highlights	13/11
Achilles Therapeutics plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Achilles Therapeutics Receives Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement	22-09-23
Syncona's portfolio Achilles Therapeutics net loss narrows	04-08-23
Achilles Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights	04-08-23
Achilles Therapeutics : Corporate Presentation – August 2023	04-08-23
Achilles Therapeutics plc Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	04-08-23
Achilles Therapeutics : THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION - Form 6-K	29-06-23
IO Summit EU 2023 - Personalised Neoantigen Therapies: State of the Art Neoantigen Immunogenicity Prediction	22-06-23
Achilles Therapeutics : SAE Cell and Gene Therapy 2023 - Targeting Clonal Neoantigens in Cancer	22-06-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Achilles Therapeutics plc

Aandelen

ACHL

US00449L1026

Andere talen

Filters